Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID‐19 intensive care unit patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID‐19 intensive care unit patients

Published:2022-12-26 Issue:5 Volume:89 Page:1617-1628
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Romano Lorenzo G. R.¹^ORCID,Hunfeld Nicole G. M.²³^ORCID,Kruip Marieke J. H. A.¹^ORCID,Endeman Henrik³,Preijers Tim²⁴^ORCID

Affiliation:

1. Department of Hematology, Erasmus MC Erasmus University Medical Center Rotterdam Rotterdam The Netherlands

2. Department of Hospital Pharmacy, Erasmus MC Erasmus University Medical Center Rotterdam Rotterdam The Netherlands

3. Department of Intensive Care, Erasmus MC Erasmus University Medical Center Rotterdam Rotterdam The Netherlands

4. Rotterdam Clinical Pharmacometrics Group Rotterdam The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15634

Reference42 articles.

1. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

2. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

3. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

4. Incidence of thrombotic complications in critically ill ICU patients with COVID-19

5. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Effects of Lavandula angustifolia Oil in Experimental Carrageenan-Induced Thrombosis;Applied Sciences;2024-02-23

2. Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children’s medical center;Frontiers in Pharmacology;2024-01-31

3. Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19;Clinical Pharmacokinetics;2023-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3